Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Work with our Pharmaceutical Consulting team, and draw on the strength of the entire Informa family. Get best-in-class datasets and insights from over 500 industry-leading analyst experts. Plus benefit from years of experience in delivering custom biotech and life sciences consulting projects.
Need outside expertise? Lack available staff? Want an objective perspective? Pharma Consulting works with you to produce actionable, flexible solutions tailored to your needs. Our services help you discover new business opportunities, reduce risks, and make better, faster decisions.
How we help
You’ll benefit from:
How it works
We specialize in pharmaceutical portfolio management, commercial optimization, and research and development strategy – whatever your business needs, we have competent experts to partner with you.
Receive customized research and analysis that transforms information into actionable development plans. We cover:
Get recommendations on capturing the full commercial potential of a product, portfolio or market opportunity, and understand the value and associated risk/return for your drug development portfolio.
Authoritative data from our market-leading intelligence sources
Expertise drawn from a team of over 100 seasoned, industry specialists
Insight & value to help you make confident strategic decisions
Support for big pharma, mid-tier, biotech, generics, & medical device companies
Citeline Analytics provides customized research and analysis that transforms information on pharmaceutical clinical trials, drugs and sites into actionable intelligence for your organization.
Pharma Consulting
By Pharma Intelligence 13 Sep 2017
The Issue Our client asked us to help support their CNS product portfolio strategy by helping to understand the clinical and commercial potential of the schizophrenia market
Pharma Consulting
11 Sep 2017
The Issue: A global pharmaceutical company needed to assess the current and future competitive landscape of an early-stage analog drug to determine the possibilities of market entry and the viability of possible differentiation strategies to compete in the market.
Pharma Consulting
11 Sep 2017
The Issue: Our client wished to understand the potential impact of the competitor’s drug going generic on their brand and whether there would be any spill-over effects.
Pharma Consulting
By Pharma Intelligence 01 Jan 2016
Issue A large biotech needed the correct analogs for follow-on biologics PTS in Oncology and Respiratory programs across a range of segments to assess the risk of their portfolio
Pharma Consulting
By Pharma Intelligence 01 Jan 2016
The Issue: The client was looking to develop a deeper understanding of the payer landscape in Europe and Japan as part of an overall market opportunity assessment
UK
Timothy specializes in
+22 year(s) experience
USA
Richard specializes in
+20 year(s) experience
How can we help you?
For a personal discussion, please contact Richard Veal:
richard.veal@informa.com
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
